AT330122B - Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes - Google Patents

Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes

Info

Publication number
AT330122B
AT330122B AT1111571A AT1111571A AT330122B AT 330122 B AT330122 B AT 330122B AT 1111571 A AT1111571 A AT 1111571A AT 1111571 A AT1111571 A AT 1111571A AT 330122 B AT330122 B AT 330122B
Authority
AT
Austria
Prior art keywords
hydrolasis
glycoside
digestive
producing new
new inhibitors
Prior art date
Application number
AT1111571A
Other languages
German (de)
English (en)
Other versions
ATA1111571A (de
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Priority to AT610074A priority Critical patent/AT330126B/de
Publication of ATA1111571A publication Critical patent/ATA1111571A/de
Application granted granted Critical
Publication of AT330122B publication Critical patent/AT330122B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
AT1111571A 1970-12-28 1971-12-24 Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes AT330122B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT610074A AT330126B (de) 1970-12-28 1974-07-24 Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (2)

Publication Number Publication Date
ATA1111571A ATA1111571A (de) 1975-09-15
AT330122B true AT330122B (de) 1976-06-10

Family

ID=5792372

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1111571A AT330122B (de) 1970-12-28 1971-12-24 Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes

Country Status (28)

Country Link
US (1) US3876766A (pl)
JP (3) JPS5734996B1 (pl)
KR (1) KR780000248B1 (pl)
AR (1) AR193370A1 (pl)
AT (1) AT330122B (pl)
AU (1) AU461521B2 (pl)
BE (1) BE777387A (pl)
BG (3) BG25654A3 (pl)
CA (1) CA979833A (pl)
CH (1) CH594051A5 (pl)
CS (1) CS167961B2 (pl)
DD (1) DD99395A5 (pl)
DE (1) DE2064092C2 (pl)
DK (1) DK139533C (pl)
ES (1) ES398358A1 (pl)
FI (1) FI49774C (pl)
FR (1) FR2120073B1 (pl)
GB (1) GB1374751A (pl)
IE (1) IE35920B1 (pl)
IL (1) IL38441A (pl)
LU (1) LU64319A1 (pl)
NL (1) NL175199C (pl)
NO (1) NO135873C (pl)
PL (1) PL82900B1 (pl)
RO (3) RO63065A (pl)
SE (1) SE398357B (pl)
SU (1) SU454750A3 (pl)
ZA (1) ZA718677B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
EP0257418B1 (de) * 1986-08-13 1993-05-19 Hoechst Aktiengesellschaft Oxiran-Pseudooligosaccharide, Verfahren zu deren Herstellung, deren Verwendung und pharmazeutische Präparate
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
US6649755B1 (en) 1999-10-28 2003-11-18 Chong Kun Dang Pharmaceutical Corp. Process for preparing acarbose with high purity
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
JP2015501641A (ja) 2011-12-08 2015-01-19 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 関連するアクチノバクテリアの遺伝的形質転換のためのプラスミドとしての、アクチノプラネス属ｓｅ５０／１１０由来の新規な放線菌組込み接合エレメント
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
KR20220081991A (ko) 2019-10-16 2022-06-16 바이엘 악티엔게젤샤프트 아카르보스의 개선된 형성을 위한 방법
US11802838B2 (en) 2020-03-23 2023-10-31 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
NO135873B (pl) 1977-03-07
JPS6216638B2 (pl) 1987-04-14
JPS5734996B1 (pl) 1982-07-26
RO63065A (fr) 1979-02-15
JPS6234396B2 (pl) 1987-07-27
AU3721471A (en) 1973-09-27
FR2120073A1 (pl) 1972-08-11
ATA1111571A (de) 1975-09-15
DK139533B (da) 1979-03-05
NO135873C (pl) 1977-06-15
NL175199C (nl) 1984-10-01
SU454750A3 (ru) 1974-12-25
BG26002A4 (bg) 1979-01-12
RO61400A (pl) 1977-01-15
SE398357B (sv) 1977-12-19
AU461521B2 (en) 1975-05-29
DK139533C (da) 1979-08-20
DD99395A5 (pl) 1973-08-05
IL38441A (en) 1974-10-22
FI49774B (pl) 1975-06-30
BG26003A4 (bg) 1979-01-12
FI49774C (fi) 1975-10-10
IE35920L (en) 1972-06-28
BG25654A3 (bg) 1978-11-10
IE35920B1 (en) 1976-06-23
DE2064092A1 (de) 1972-07-20
PL82900B1 (pl) 1975-10-31
BE777387A (fr) 1972-06-28
JPS57150396A (en) 1982-09-17
CA979833A (en) 1975-12-16
ES398358A1 (es) 1974-09-01
NL175199B (nl) 1984-05-01
AR193370A1 (es) 1973-04-23
FR2120073B1 (pl) 1975-12-26
ZA718677B (en) 1972-09-27
CS167961B2 (pl) 1976-05-28
JPS57150395A (en) 1982-09-17
LU64319A1 (pl) 1972-06-13
NL7117893A (pl) 1972-06-30
IL38441A0 (en) 1972-02-29
DE2064092C2 (de) 1983-06-01
GB1374751A (en) 1974-11-20
US3876766A (en) 1975-04-08
CH594051A5 (pl) 1977-12-30
RO63064A (fr) 1978-06-15
KR780000248B1 (en) 1978-07-06

Similar Documents

Publication Publication Date Title
AT330122B (de) Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes
AT319235B (de) Verfahren zur Herstellung von neuen 8-Azapurin-6-on-derivaten
AT311557B (de) Verfahren zur Herstellung von neuen α-Aminopenicillinen
AT339901B (de) Verfahren zur herstellung von neuen tetrazolderivaten
AT303270B (de) Verfahren zur Herstellung von neuen Glucosiden
AT326138B (de) Verfahren zur herstellung von neuen azetidin-2-on-derivaten
AT297024B (de) Verfahren zur Herstellung des neuen Di-adenin-pyridoxal-phosphates
AT330760B (de) Verfahren zur herstellung von neuen derivaten des 2-amino-indans
AT327211B (de) Verfahren zur herstellung von neuen azetidinderivaten
AT328461B (de) Verfahren zur herstellung von neuen azetidinderivaten
AT323902B (de) Verfahren zur herstellung von neuen thio-pyrimidin-derivaten
AT310148B (de) Verfahren zur Herstellung von neuen Norpinanderivaten
AT309075B (de) Verfahren zur Herstellung von neuen Cyclocopolymeren
AT312166B (de) Verfahren zur herstellung von neuen alkalipolymetaphosphatkomplexen des alpha-6-desoxy-5-hydroxytetracyclins
AT330126B (de) Verfahren zur herstellung von neuen inhibitoren fur glykosidhydrolasen des verdauungstraktes
CH536358A (de) Verfahren zur Herstellung des neuen Antibiotikums Largomycin
CH515327A (de) Verfahren zur Herstellung des neuen Antibiotikums Thiopeptin
AT309705B (de) Verfahren zur Herstellung von neuen 21-Floursteroiden
AT310958B (de) Verfahren zur Herstellung von neuen Octadecapeptiden
AT300834B (de) Verfahren zur Herstellung von neuen Cyclophosphaten
AT307395B (de) Verfahren zur Herstellung des neuen 7-Formylacenaphthens
AT321902B (de) Verfahren zur herstellung von neuen naphthochinonderivaten
AT303256B (de) Verfahren zur Herstellung des neuen Antibiotikums Axenomycin D
AT323906B (de) Verfahren zur herstellung von neuen östratrienen
AT308985B (de) Verfahren zur Herstellung von neuen 16α18-Dimethylpregnenen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee